All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma a randomised, double-blind phase III trial

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11150%2F07%3A00003860" target="_blank" >RIV/00216208:11150/07:00003860 - isvavai.cz</a>

  • Result on the web

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma a randomised, double-blind phase III trial

  • Original language description

    Background vascular endothelial growth factor(VEGF) inhibition is a valid therapeutic approach in renal cell carcinoma.

  • Czech name

    Bevacizumab plus interferon alf 2a při léčbě metastáz ledvin

  • Czech description

    Cévní endoteliální nádorový faktor (VEGF)potlačení je odůvodněným léčebným postupem při rakovině ledvinových buněk.

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FD - Oncology and haematology

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/NR8392" target="_blank" >NR8392: Predictive and prognostic factors in breast cancer patients treated with neoadjuvant chemotherapy</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2007

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Lancet

  • ISSN

    0140-6736

  • e-ISSN

  • Volume of the periodical

    370

  • Issue of the periodical within the volume

    9605

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    9

  • Pages from-to

    2103-2111

  • UT code for WoS article

  • EID of the result in the Scopus database